Search
Dr Alexandros Georgiou

Dr Alexandros Georgiou

Medical oncology 07017572

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Offers

  • Face-to-face consultations
  • Video and telephone consultations

About me

Dr Alex Georgiou is a medical oncology consultant. He specialises in the treatment of lung cancer, mesothelioma, and thymic cancers.

Dr Alex Georgiou is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Hospital in London (GSTT) and King's College Hospitals. Presently, he also serves as the clinical service lead for all Systemic Anti-Cancer Therapies (SACT) at GSTT.

He is the UK chief investigator and principal investigator at GSTT in multiple international clinical trials investigating novel treatments for lung cancer and mesothelioma. He is also an honorary senior lecturer at King's College London (KCL) and leads on academic research at KCL and GSTT aiming to enhance the early diagnosis, treatment, and outcomes for lung cancer patients.

He completed his medical oncology training at the Royal Marsden Hospital (RMH) in London, 2012-2019. During his training he secured competitive Cancer Research UK (CRUK) funding, which supported his successful three-year PhD (2015-2018) at the Institute of Cancer Research (ICR) London. His doctoral research explored the mechanisms of resistance to targeted anti-cancer therapies, earning him a Merit award from the European Society of Medical Oncology Congress (ESMO) in 2018 and a University of London scholarship in 2019.

He has an extensive publication record in oncology and in particular lung cancer and has been invited to speak at both national and international oncology conferences. Additionally, he provides clinical advice to 'EGFR Positive UK', a UK lung cancer charity.

Profile including patient reviews: https://www.doctify.com/uk/specialist/alexandros-georgiou

Publications can be found here: https://www.researchgate.net/profile/Alexandros-Georgiou

Areas of interest

Lung cancer; non-small cell lung cancer; small cell lung cancer; lung adenocarcinoma; mesothelioma; thymoma; thymic malignancies; targeted therapies; immunotherapy; chemotherapy; EGFR; ALK ROS1; KRAS;

Medical secretaries

About me
My qualifications & training
Consultant's practices
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.